Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
US8840872B2 · kind B2 · utility
3Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2011 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Aug 8, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.